MEG3 and juvenile Huntington disease: Recent studies have shown that the lncRNA MEG3 is associated with glioma, Huntington's disease, stroke, and other neurological disorders, suggesting a potentially new clinical biomarker (15, 16), it can block the cell cycle by activating the p53 pathway, leading to cell replication senescence or apoptosis.